![U.S. FDA approval](https://worldschooloflifesciencesip.com/wp-content/uploads/2023/09/Untitled-design-5-2.png)
U.S. FDA approval of BioLineRx’s APHEXDA™ (Motixafortide) in combination with Filgrastim (G-CSF) – a ray of hope for patients with Multiple Myeloma
U.S. FDA approval of BioLineRx’s APHEXDA™ (Motixafortide) in combination with Filgrastim (G-CSF) – a ray of hope for patients with Multiple Myeloma BioLineRx Ltd., a